세계의 감염증 검사 시장 - 산업 규모, 점유율, 동향, 기회, 예측 : 제품 및 서비스별, 기술별, 질환별, 최종 사용자별, 지역별, 경쟁별(2020-2030년)
Infectious Disease Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product & Service, By Technology, By Disease, By End User, By Region and Competition, 2020-2030F
상품코드:1785152
리서치사:TechSci Research
발행일:2025년 08월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 감염증 검사 시장 규모는 2024년에 340억 9,000만 달러에 달했으며, 2030년까지의 CAGR은 7.71%를 나타내 예측 기간 동안 눈부신 성장을 이룰 것으로 예상되고 있습니다.
박테리아, 기생충, 바이러스, 곰팡이는 감염의 원인 물질입니다. 이러한 질병의 확인과 특성 분석은 감염성 진단학의 영역에 속합니다. 의사와 의료 전문가는 감염의 발견을 주로 환자의 증상과 신체 검사에 의존합니다. 다양한 임상 검사를 실시하여 원인 병원체를 확인하여 의료 제공업체가 적절한 치료를 할 수 있도록 합니다. 병원체는 직접 접촉, 물과 식품을 통한 경로, 환경에서 감염된 입자의 에어로졸화, 심지어 곤충(모기 및 기타)과 마다니를 통해 감염될 수 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
340억 9,000만 달러
시장 규모 : 2030년
528억 1,000만 달러
CAGR : 2025-2030년
7.71%
급성장 부문
병원 및 임상 실험실
최대 시장
북미
면역력이 떨어지는 사람은 특정 감염에 특히 걸리기 쉽습니다. 여기에는 암 치료 중 환자와 장기 이식을 받은 지 얼마 안된 환자가 포함됩니다. 일반적인 감염에 대한 예방 접종을 받지 않은 사람, 건강 관리 종사자, 말라리아 및 뎅기열과 같은 모기가 매개하는 병원체가 존재하는 위험이 높은 지역으로 여행하는 사람은 그 위험이 높아집니다. 의사가 감염을 진단할 때 다양한 임상 검사가 수행됩니다. 세계의 감염증 검사 시장은 다양한 전염병의 적시 진단 및 관리에 중요한 역할을 하고 있습니다. 바이러스 감염과 세균 감염의 유행이 확대되고 있는 가운데, 헬스케어 시스템 전체에 있어서, 신속하고 정확하고, 이용하기 쉬운 진단 툴에 대한 요구가 높아지고 있습니다. 이 시장에는 HIV, 간염, 결핵, 인플루엔자, 최근에는 COVID-19 및 원숭이두와 같은 신흥 위협과 같은 질병 검사 솔루션이 포함됩니다.
기술의 진보는 주요 촉진요인이며, 특히 분자진단, 포인트 오브 케어 검사, 검사실 자동화의 채용이 두드러집니다. 이러한 혁신은 신속한 납기, 감도 및 특이성 향상, 질병 감시 개선을 가능하게 합니다. 재택치료나 원격 진료소 등 분산화된 헬스 케어 환경의 확대는 휴대 가능하고 사용하기 쉬운 검사 키트 수요를 더욱 가속화하고 있습니다. 예를 들어, 모로코의 생명공학 기업인 몰디아그는 2024년 12월 아프리카 최초의 국산 엠폭스 검사 키트를 출시하여 아프리카 대륙의 건강 관리 자급률 강화에 있어 큰 이정표가 되었습니다. 이 개발은 진단 도구의 수입 의존도를 감소시키고 감염의 발생에 대응하는 지역적 능력을 강화시킵니다. Moldiag의 이니셔티브는 아프리카의 생명 공학 인프라를 구축하고 필수적인 진단 솔루션에 적시에 액세스를 개선하는 데 중요한 전진을 의미합니다.
시장 성장 촉진요인
감염의 유행 증가
주요 시장 과제
불충분한 상환
주요 시장 동향
포인트 오브 케어 검사(POCT)
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 목소리
제5장 세계의 감염증 검사 시장 전망
시장 규모와 예측
금액별
시장 점유율·예측
제품 및 서비스별(분석, 키트, 시약, 기기, 서비스 및 소프트웨어)
기술별(분자진단, 면역 분석, 미생물학, 기타)
질환별(간염, 인유두종 바이러스(HPV), 인간 면역 결핍 바이러스(HIV), 결핵(TB), 병원획득감염(HAI), 기타)
최종 사용자별(병원 및 임상 실험실, 진단 참조 실험실, 학술/연구 기관, 기타)
지역별
기업별(2024년)
시장 맵
제6장 북미의 감염증 검사 시장 전망
시장 규모와 예측
시장 점유율·예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 감염증 검사 시장 전망
시장 규모와 예측
시장 점유율·예측
유럽 : 국가별 분석
독일
영국
이탈리아
프랑스
스페인
제8장 아시아태평양의 감염증 검사 시장 전망
시장 규모와 예측
시장 점유율·예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 남미의 감염증 검사 시장 전망
시장 규모와 예측
시장 점유율·예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 감염증 검사 시장 전망
시장 규모와 예측
시장 점유율·예측
중동 및 아프리카 : 국가별 분석
남아프리카
사우디아라비아
아랍에미리트(UAE)
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
최근 동향
합병과 인수
제품 출시
제13장 세계의 감염증 검사 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계 내 경쟁
신규 진입의 가능성
공급자의 힘
고객의 힘
대체품의 위협
제15장 경쟁 구도
Biomerieux SA
Abbott Laboratories Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories Inc.
Danaher Corporation
F. Hoffmann-La Roche AG
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
Quidel Corporation
Trinity Biotech PLC
제16장 전략적 제안
제17장 기업 소개와 면책사항
KTH
영문 목차
영문목차
Global Infectious Disease Testing Market has valued at USD 34.09 Billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.71% through 2030F. Bacteria, parasites, viruses, and fungi are the causative agents of infectious diseases. The identification and characterization of these diseases fall under the domain of infectious disease diagnostics. Physicians and healthcare professionals primarily rely on patients' symptoms and physical examinations to detect infectious infections. A range of laboratory tests is conducted to determine the causative agents, enabling healthcare providers to administer appropriate medical treatments. Pathogens can be transmitted through direct contact, water or foodborne routes, aerosolization of infected particles in the environment, as well as via insects (such as mosquitoes) and ticks.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 34.09 Billion
Market Size 2030
USD 52.81 Billion
CAGR 2025-2030
7.71%
Fastest Growing Segment
Hospitals & Clinical Laboratories
Largest Market
North America
Individuals with compromised immune systems are particularly vulnerable to certain infections. This includes those undergoing cancer treatment or recent organ transplant recipients. The individuals who have not been vaccinated against common infectious diseases, healthcare workers, and those traveling to high-risk areas with mosquito-borne pathogens like malaria and dengue fever are at increased risk. Various laboratory tests are employed by doctors to diagnose infectious disorders. The global infectious disease testing market plays a critical role in the timely diagnosis and management of a wide array of contagious illnesses. With the growing prevalence of both viral and bacterial infections, there is a heightened need for rapid, accurate, and accessible diagnostic tools across healthcare systems. The market includes testing solutions for diseases such as HIV, hepatitis, tuberculosis, influenza, and more recently, emerging threats like COVID-19 and monkeypox.
Technological advancements have been a key driver, particularly the adoption of molecular diagnostics, point-of-care testing, and automation in laboratories. These innovations enable quicker turnaround times, increased sensitivity and specificity, and improved disease surveillance. The expansion of decentralized healthcare settings, such as home care and remote clinics, has further spurred demand for portable and easy-to-use test kits. For instance, in December 2024, Moroccan biotech company Moldiag launched Africa's first locally produced mpox test kits, representing a major milestone in strengthening the continent's healthcare self-sufficiency. This development reduces dependence on imported diagnostic tools and enhances regional capacity to respond to infectious disease outbreaks. Moldiag's initiative marks a critical advancement in building Africa's biotechnology infrastructure and improving timely access to essential diagnostic solutions.
Key Market Drivers
Increasing Prevalence of Infectious Diseases
The global infectious disease testing market is experiencing significant growth due to the increasing prevalence of infectious diseases worldwide. The rising prevalence of infectious diseases, particularly tuberculosis (TB), is a key driver of growth in the global infectious disease testing market. According to WHO, TB caused 1.25 million deaths in 2023, making it the world's leading infectious killer, surpassing COVID-19. With an estimated 10.8 million people falling ill globally, including many with drug-resistant TB, the demand for early, accurate, and accessible diagnostic testing continues to rise. The persistent emergence and re-emergence of infectious diseases have heightened the demand for accurate and timely diagnostic solutions. Outbreaks of diseases like COVID-19, Ebola, Zika, and antibiotic-resistant bacterial infections have underscored the need for rapid and efficient testing methods to detect, track, and manage these diseases. The globalization of travel and trade has facilitated the rapid spread of infectious agents across borders, making early detection and containment crucial to prevent outbreaks. This has driven up the demand for robust infectious disease testing infrastructure, including diagnostic assays, testing equipment, and surveillance systems.
The aging global population is more susceptible to infectious diseases, particularly due to compromised immune systems. As a result, there is a heightened focus on early detection and monitoring of infections in elderly individuals, contributing to market growth.
The rising awareness among healthcare professionals and the general public about the importance of early diagnosis and prompt treatment has also fueled demand. Timely infectious disease testing not only aids in better patient care but also helps in preventing the spread of diseases within communities. The increasing prevalence of infectious diseases, coupled with the need for rapid and accurate diagnosis, has led to substantial growth in the global infectious disease testing market. As infectious disease threats continue to evolve, the market is expected to further expand, with ongoing advancements in testing technologies and increased investment in public health infrastructure playing pivotal roles in addressing these global health challenges.
Key Market Challenges
Inadequate Reimbursements
Inadequate reimbursements within healthcare systems can indeed have a negative impact on the demand for global infectious disease testing. Reimbursements play a critical role in healthcare economics, affecting both healthcare providers and patients. When reimbursement rates for infectious disease testing are insufficient, healthcare providers, including hospitals, clinics, and laboratories, may struggle to cover the costs associated with testing. This financial strain can lead to reduced investment in testing infrastructure, limited availability of testing services, and even closures of diagnostic facilities in underserved areas.
Inadequate reimbursement rates can deter healthcare providers from offering a comprehensive range of infectious disease testing services. This may result in reduced access to critical diagnostic tests, leaving patients with limited options for early disease detection and management. Lower reimbursement rates can discourage laboratories and diagnostic companies from investing in research and development to improve testing accuracy, speed, and accessibility. This can stifle innovation and hinder the development of more advanced and cost-effective testing solutions. Reduced access to infectious disease testing due to inadequate reimbursements can exacerbate healthcare disparities, disproportionately affecting underserved populations. These disparities can result in delayed diagnoses and poorer health outcomes in vulnerable communities.
Key Market Trends
Point-of-Care Testing (POCT)
POCT devices that offer rapid results and can be used outside traditional healthcare settings will continue to gain popularity. They are especially valuable in resource-limited and remote areas. POCT devices are designed to be user-friendly and portable, making them accessible even in areas with limited healthcare infrastructure. They can be used in remote clinics, field hospitals, and rural communities, bringing essential diagnostic capabilities closer to patients.
In resource-limited and remote areas, access to centralized laboratories for traditional testing can be challenging. POCT devices offer the advantage of providing immediate results, allowing healthcare providers to diagnose and initiate treatment promptly. This is crucial for managing infectious diseases effectively and preventing their spread. Rapid results from POCT devices mean that patients do not have to wait for days or weeks to receive their test results. This helps alleviate anxiety, enables timely medical decisions, and improves patient satisfaction. POCT devices often require lower initial investments compared to establishing and maintaining a fully equipped laboratory. This cost-effectiveness is particularly valuable for healthcare facilities with limited budgets.
Key Market Players
Biomerieux SA
Abbott Laboratories Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories Inc.
Danaher Corporation
F. Hoffmann-La Roche AG
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
Quidel Corporation
Trinity Biotech PLC
Report Scope:
In this report, the Global Infectious Disease Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Infectious Disease Testing Market, By Product & Service:
Assays
Kits
Reagents
Instruments
Services & Software
Infectious Disease Testing Market, By Technology:
Molecular Diagnostics
Immunoassay
Microbiology
Others
Infectious Disease Testing Market, By Disease:
Hepatitis
Human Papillomavirus (HPV)
Human Immunodeficiency Virus (HIV)
Tuberculosis (TB)
Hospital-Acquired Infections (HAIs)
Others
Infectious Disease Testing Market, By End User:
Hospital and Clinical Laboratories
Diagnostic Reference Laboratories
Academic/Research Institutes
Others
Infectious Disease Testing Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Infectious Disease Testing Market.
Available Customizations:
Global Infectious Disease Testing market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Infectious Disease Testing Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product & Service (Assays, Kits, Reagents, Instruments, Services & Software)
5.2.2. By Technology (Molecular Diagnostics, Immunoassay, Microbiology, Others)
5.2.3. By Disease (Hepatitis, Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Hospital-Acquired Infections (HAIs), Others)
5.2.4. By End User (Hospital and Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Others)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Infectious Disease Testing Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product & Service
6.2.2. By Technology
6.2.3. By Disease
6.2.4. By End User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Infectious Disease Testing Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product & Service
6.3.1.2.2. By Technology
6.3.1.2.3. By Disease
6.3.1.2.4. By End User
6.3.2. Canada Infectious Disease Testing Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product & Service
6.3.2.2.2. By Technology
6.3.2.2.3. By Disease
6.3.2.2.4. By End User
6.3.3. Mexico Infectious Disease Testing Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product & Service
6.3.3.2.2. By Technology
6.3.3.2.3. By Disease
6.3.3.2.4. By End User
7. Europe Infectious Disease Testing Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product & Service
7.2.2. By Technology
7.2.3. By Disease
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Infectious Disease Testing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product & Service
7.3.1.2.2. By Technology
7.3.1.2.3. By Disease
7.3.1.2.4. By End User
7.3.2. United Kingdom Infectious Disease Testing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product & Service
7.3.2.2.2. By Technology
7.3.2.2.3. By Disease
7.3.2.2.4. By End User
7.3.3. Italy Infectious Disease Testing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecasty
7.3.3.2.1. By Product & Service
7.3.3.2.2. By Technology
7.3.3.2.3. By Disease
7.3.3.2.4. By End User
7.3.4. France Infectious Disease Testing Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product & Service
7.3.4.2.2. By Technology
7.3.4.2.3. By Disease
7.3.4.2.4. By End User
7.3.5. Spain Infectious Disease Testing Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product & Service
7.3.5.2.2. By Technology
7.3.5.2.3. By Disease
7.3.5.2.4. By End User
8. Asia-Pacific Infectious Disease Testing Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product & Service
8.2.2. By Technology
8.2.3. By Disease
8.2.4. By End User
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Infectious Disease Testing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product & Service
8.3.1.2.2. By Technology
8.3.1.2.3. By Disease
8.3.1.2.4. By End User
8.3.2. India Infectious Disease Testing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product & Service
8.3.2.2.2. By Technology
8.3.2.2.3. By Disease
8.3.2.2.4. By End User
8.3.3. Japan Infectious Disease Testing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product & Service
8.3.3.2.2. By Technology
8.3.3.2.3. By Disease
8.3.3.2.4. By End User
8.3.4. South Korea Infectious Disease Testing Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product & Service
8.3.4.2.2. By Technology
8.3.4.2.3. By Disease
8.3.4.2.4. By End User
8.3.5. Australia Infectious Disease Testing Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product & Service
8.3.5.2.2. By Technology
8.3.5.2.3. By Disease
8.3.5.2.4. By End User
9. South America Infectious Disease Testing Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product & Service
9.2.2. By Technology
9.2.3. By Disease
9.2.4. By End User
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Infectious Disease Testing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product & Service
9.3.1.2.2. By Technology
9.3.1.2.3. By Disease
9.3.1.2.4. By End User
9.3.2. Argentina Infectious Disease Testing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product & Service
9.3.2.2.2. By Technology
9.3.2.2.3. By Disease
9.3.2.2.4. By End User
9.3.3. Colombia Infectious Disease Testing Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product & Service
9.3.3.2.2. By Technology
9.3.3.2.3. By Disease
9.3.3.2.4. By End User
10. Middle East and Africa Infectious Disease Testing Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product & Service
10.2.2. By Technology
10.2.3. By Disease
10.2.4. By End User
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Infectious Disease Testing Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product & Service
10.3.1.2.2. By Technology
10.3.1.2.3. By Disease
10.3.1.2.4. By End User
10.3.2. Saudi Arabia Infectious Disease Testing Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product & Service
10.3.2.2.2. By Technology
10.3.2.2.3. By Disease
10.3.2.2.4. By End User
10.3.3. UAE Infectious Disease Testing Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product & Service
10.3.3.2.2. By Technology
10.3.3.2.3. By Disease
10.3.3.2.4. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Global Infectious Disease Testing Market: SWOT Analysis
